Table 2.

Overview of participants, recruitment period, patient diagnosis and medical therapy

Reference, country	N	Mean age (years)	Male participants (%)	Recruitment period (years)	Maximum follow-up period	Patient diagnosis	Medication
Aronov et al,39 Russia	392	61.4	73.5	None specified	1 year	AMI, stable angina, unstable angina or myocardial revascularisation.	Standard medical therapy: β-blocker, acetylsalicyclic acid or other antithrombotic drug, nitrate, ACE inhibitor. Some patients on lipid-lowering drugs.
Belardinelli et al,32 Italy	118	61	100	None specified	33 months	CAD including AMI. Successful PCI in one or two native epicardial coronary arteries only.	According to international accepted protocols: aspirin, ticlopidine, calcium antagonists and nitrates.
Briffa et al,40 Australia	113	47.5	89.5	None specified	1 year	Uncomplicated AMI or recovery from unstable angina. PCI, CABG, thrombolytic therapy.	Aspirin, antiarrhytmic agent, β-blocker, ACE inhibitor, calcium antagonist, long-acting nitrate and diuretic.
Giallauria et al,33 Italy	61	58.5	78.5	None specified	6 months	AMI and undergone primary or rescue PCI only.	Aspirin, β-blocker, ACE inhibitor, ARB and statin.
Hambrecht et al,30 Germany	101	56	87.3	1997–2001	1 year	Stable CAD defined by angina pectoralis and amenable to PCI. AMI patients excluded.	β-receptor antagonists, β-HMG-CoA reductase inhibitors, ACE inhibitor and acetylsalicyclic acid.
Higgins et al,41 Australia	105	60.8	81.3	1995–1997	51 weeks	Post-PCI patients only. No AMI 1-month preprocedure.	Reference to medical therapy, only breakdown for lipid-lowering medication.
Houle et al,42 Canada	65	51.5	100	2007–2008	12 months	Patients hospitalised for an ACS (unstable angina, non-ST-elevation or ST elevation MI). PCI, CABG or no revascularisation procedure.	Reference to medication in usual care group but no breakdown.
Kovoor et al,43 Australia	142	51.5	100	None specified	6 months	AMI only. Thrombolytic therapy, one patient in the exercise treatment group had primary angioplasty.	Aspirin, β-blocker, ACE inhibitor, calcium channel blockers, nitrates and cholesterol-lowering agents.
Maddison et al,44 New Zealand	171	59	20	2010–2012	24 weeks	Diagnosis of IHD (angina, MI, revascularisation, including angioplasty, stent or CABG).	No description.
Maroto et al,34 Spain	180	76.9	57.5	(None specified) 2-year enrolment period	10 years	AMI only.	Medication regimens employed in secondary prevention at discharge were clearly insufficient by standard criteria but currently meet Spanish and European guidelines.
Munk et al,35 Norway	40	56.4	84.8	None specified	6 months	Stable angina and unstable angina, post-PCI only. AMI patients excluded.	Aspirin, β-blocker, ACE inhibitor, ARB, statin and acetylsalicyclic acid.
Mutwalli et al,45 Saudi Arabia	49	69.7	100	2008–2010	6 months	Undergone CABG surgery. Unknown whether AMI patients included.	Participants received advice that focused on medications, no breakdown.
Oerkild et al,36 Denmark	40	63.5	0	2007–2008	12 months (mortality data after 5.5 years)	Recent coronary event defined as AMI, PCI, CABG or without invasive procedure.	β-blocker, antithrombotics, calcium antagonists, lipid-lowering agents and diuretics.
Reid et al,46 Canada	223	54.5	87.3	2004–2007	12 months	ACS including AMI, underwent successful PCI only.	Reference to a ‘descriptive summary in supplemental table’, no access.
Santaularia et al,29 Spain	85	59.6	84.7	None specified	12 months	AMI only, no evidence of revascularisation procedure.	Reference to cardiac medication but no breakdown
Seki et al,47 Japan	39	57.8	83.8	None specified	NR	AMI, PCI or CABG.	Reference to ‘lipid-lowering drugs and other medications’, no breakdown.
Toobert et al,48 USA	25	64.5	0	None specified	24 months	CAD defined as atherosclerosis, AMI, PCI or CABG.	Antihypertensive and hypolipidaemic medications.
Vestfold Heartcare Study Group,37 Norway	197	64	75.8	None specified	2 years	AMI, unstable angina pectoris or after PCI or CABG.	Aspirin, β-blocker, statin, ACE inhibitor, calcium antagonist and warfarin.
Wang et al,49 China	160	67	63.5	2005–2007	6 months	AMI only.	Antiplatelet, nitrate, β-blocker, ACE inhibitor, calcium antagonist and statin.
West et al,31 UK	1813	51.9	93.9	1997–2000	7–9 years	AMI only.	Aspirin, β-blocker, ACE inhibitor, diuretic, long-acting nitrate/calcium channel blocker, statin and GTN.
Yu et al,50 China	269	56	83.9	None specified	2 years	Recent AMI, after elective PCI or thrombolytic therapy.	Antiplatelet, β-blocker, calcium channel blocker, nitrate, statin, ACE inhibitor and diuretic.
Zwisler et al,38 Denmark	446	55.5	72.1	2000–2003	1 year	AMI, angina pectoris or after PCI or CABG.	Antithrombotics, lipid-lowering drugs, β-blocker, calcium antagonists, ACE inhibitor, diuretic and long-acting nitrates.

ACS, acute coronary syndrome; AMI, acute myocardial infarction; ARB, angiotensin receptor blockers; CABG, coronary artery bypass graft; CAD, coronary artery disease; GTN, glyceryl trinitrate; IHD, ischaemic heart disease; MI, myocardial infarction; PCI, percutaneous coronary intervention.